FAST NEWS: New Horizon Health CFO, auditor resign

6606.HK
New Horizon Health was China’s first cancer-screening device company to go public, and was once the envy of the industry as its revenue surged more than 20 times in the three years through 2023 and its gross margin jumped from 52% to 90%.

The Latest: Cancer-screening device maker New Horizon Health Ltd. (6606.HK) announced Monday that Deloitte has resigned as its auditor, effective Sept. 9. Separately, the company said its CFO Gao Yu also announced his resignation, effective Sept. 30th.

Looking Up: The company is in the process of identifying a new auditor to fill the vacancy so it can complete its overdue 2023 audit as soon as possible.

Take Note: The company’s financial data was previously questioned by a short seller, suggesting that the auditor’s and CFO’s resignation may be related to accounting irregularities discovered after an investigation into the allegations.

Digging Deeper: New Horizon Health was China’s first cancer-screening device company to go public, and was once the envy of the industry as its revenue surged more than 20 times in the three years through 2023 and its gross margin jumped from 52% to 90%. But those strong results were challenged last year by short seller CapitalWatch. In March this year, New Horizon’s auditor, Deloitte, said an independent investigation into the company’s financial data was needed. The company was subsequently unable to publish its annual report for 2023 and trading in its shares has been suspended since then.

Market Reaction: New Horizon Health’s shares have been suspended since March 28. They last traded at HK$14.14, near the lower end of their 52-week range.

Translation by A. Au

To subscribe to Bamboo Works weekly free newsletter, click here

,
, , , ,

Related Articles

RELATED ARTICLES

  1. Horizon Robotics makes smart chips
    Horizon’s lead grows in smart driving race with new product rollouts
    9660.HK
  2. Everest Medicines drives growth with AI-powered mRNA pipeline
    1952.HK
  3. Auditor drama casts unflattering light on Lufax at already-difficult time
    6623.HK LU.US
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

Recent Articles

Illustration of Hong Kong as a ipo pipeline and crypto lab for China

Hong Kong: China’s IPO pipeline and crypto lab

Companies raised $13.6 billion through Hong Kong IPOs in the first half of the year, giving the city the global fundraising title for that period. What's behind the sudden boom? And a growing number of Chinese companies are experimenting with cryptocurrencies in Hong Kong, even as such currencies are banned on the Mainland. What's driving such different approaches on the Mainland and in Hong Kong?